Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Asian Harmonization Working Party names new executive team

This article was originally published in Clinica

Executive Summary

Wang Baoting has been named chairperson of the Asian Harmonization Working Party (AHWP). Mr Wang is the director general of the department of medical devices of China’s State Food and Drug Administration. He takes over from Mukundan Pillay for a three-year term. Milind Shah, managing director of Medtronic India, has been appointed as the AHWP’s co-chair. This signals that India will supply the next AHWP chair (the actual candidate is not yet known, but must be selected from among the country’s regulatory personnel). The AHWP’s new secretariat will consist of: Dr Jiang Feng and Dr Zu Xue Jun, of the China Association for the Medical Devices Industry; Jack Wong, of the BSI; and Bryan So, of the Hong Kong Productivity Council. Serving on the AHWP’s new technical committee are: Alfred Kwek (Health Sciences Authority, Singapore), as chair; and co-chairs Ali Al-Dalaan, of the Saudi Food & Drug Authority, and Daphne Yeh, of Philips Taiwan. Jack Wong is named as technical committee secretary.

You may also be interested in...

Asia Regulatory Forum Update

Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.

Saudi Arabia adopts interim device authorisation regulation

Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.

Canada takes action to increase more adverse event reporting

The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts